Avedro is seeking to gain FDA approval for its KXL Lasik device platform. The device platform has received CE Mark for sale outside of the US and is currently undergoing Phase III clinical studies within the US.
More Articles on Ophthalmology:
Miller School of Medicine, International Team Discover Seven Genes Linked to Macular Degeneration
Report Estimates Optical Imaging Market Worth $1.9B by 2018
$11.5M in Series A Funding Awarded to Kala Pharmaceuticals
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
